Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483 · cited 1×
“OPG-deficient mice tend to exhibit both osteoporosis with multiple fractures and calcification of the aorta and renal arteries, suggesting that OPG can influence vascular calcification [41].”
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., & Karsenty, G. (1997) · Nature · doi:10.1038/386078a0 · Cited by 2,120 · cited 1×
“Mice that are deficient in GLa proteins demonstrate extensive vascular calcification, abnormal cartilage calcification and osteoporosis, which suggest that dysregulation of these proteins may result in abnormal mineralization of both bones and arteries [ 34 ].”
BackgroundChen, D., Zhao, M., & Mundy, G. R. (2004) · Growth Factors · doi:10.1080/08977190412331279890 · Cited by 1,915 · cited 1×
“TGF-β plays a pivotal role in the regulation of osteoblast differentiation and proliferation [36].”
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,774 · cited 1×
“Moreover, a substantial increase in bone formation and trabecular bone volume has been reported in female rats after 5 weeks of administration of simvastatin [98].”
BackgroundHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“OPG is secreted mainly by osteoblast lineage cells [39].”
BackgroundLuckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176 · cited 1×
“The protective effect of biphosphonates has been attributed to their direct action on the vessel wall by sensitizing macrophages to undergo apoptosis, preventing foam cell formation by inhibiting the uptake of LDL and affecting cell replication [104].”
Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174 · cited 1×
“Markers of inflammation such as interleukin-6 (IL-6) and C-reactive protein (CRP) have been associated with all-cause and cardiovascular mortality in both sexes [73].”
BackgroundThe Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146 · cited 1×
“On the other hand, IL-6 is known to stimulate osteoclasts to increase the rate of bone resorption [74].”
BackgroundLDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128 · cited 1×
“They bind to receptor complexes, including LDL receptor-related proteins (LRP)-5 and LRP-6, as well as frizzled proteins [45].”
BackgroundGallagher, J. C., Riggs, B. L., Eisman, J., Hamstra, A., Arnaud, S. B., & Deluca, H. F. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109516 · Cited by 861 · cited 1×
“The role of vitamin D in bone metabolism through calcium absorption is well established [77].”
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 1×
“Induction of NFkB exerts proatherogenic effects in the vessel wall [44].”
Byon, C. H., Javed, A., Dai, Q., Kappes, J. C., Clemens, T. L., Darley-Usmar, V. M., McDonald, J. M., & Chen, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800021200 · Cited by 638 · cited 1×
“It appears to participate in the induction of vascular smooth cell calcification by oxidative stress [ 51 ].”
BackgroundHigh expression of genes for calcification-regulating proteins in human atherosclerotic plaques.
Shanahan, C. M., Cary, N. R., Metcalfe, J. C., & Weissberg, P. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117246 · Cited by 611 · cited 8×
“Pravastatin seems to be ineffective at increasing BMP-2 as it binds less strongly to plasma proteins than do other statins, such as lovastatin, simvastatin or fluvastatin [101].”
InfluentialLRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors
Mani, A., Radhakrishnan, J., Wang, H., Mani, A., Mani, M.-A., Nelson-Williams, C., Carew, K. S., Mane, S., Najmabadi, H., Wu, D., et al. (2007) · Science · doi:10.1126/science.1136370 · Cited by 588 · cited 1×
“Recently, a missense mutation in LRP6 was identified in a family with autosomal dominant early CAD, features of the metabolic syndrome and osteoporosis [49].”
BackgroundBrowner, W. S., Lui, L.-Y., & Cummings, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7192 · Cited by 506 · cited 1×
“In one study, serum levels of OPG were about 30% greater in women with DM than in euglycaemic ones [42].”
A role for Smad6 in development and homeostasis of the cardiovascular system
Galvin, K. M., Donovan, M. J., Lynch, C. A., Meyer, R. I., Paul, R. J., Lorenz, J. N., Fairchild-Huntress, V., Dixon, K. L., Dunmore, J. H., Gimbrone, M. A., et al. (2000) · Nature Genetics · doi:10.1038/72835 · Cited by 499 · cited 1×
“Indeed, Smad6-deficient mice exhibit cartilaginous metaplasia and ossification of the aorta, indicating the role of this protein in vascular calcification [37].”
Losordo, D. W., Kearney, M., Kim, E. A., Jekanowski, J., & Isner, J. M. (1994) · Circulation · doi:10.1161/01.cir.89.4.1501 · Cited by 496 · cited 1×
“Estrogen receptors have been detected on osteoblasts, osteoclasts and coronary artery smooth muscle cells [56].”
BackgroundOrigin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.
Price, P. A., Williamson, M. K., & Lothringer, J. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42960-2 · Cited by 485 · cited 1×
“Indeed, administration of vitamin K seems to retard femoral neck bone loss in postmenopausal women [86].”
BackgroundKiel, D. P., Kauppila, L. I., Cupples, L. A., Hannan, M. T., O'Donnell, C. J., & Wilson, P. W. F. (2001) · Calcified Tissue International · doi:10.1007/bf02390833 · Cited by 483 · cited 1×
“Regarding aortic calcification (a surrogate marker of the atherosclerotic burden), some studies reported an inverse relationship with BMD [12, 13].”
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
Shao, J.-S., Cheng, S.-L., Pingsterhaus, J. M., Charlton-Kachigian, N., Loewy, A. P., & Towler, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524140 · Cited by 452
Dedifferentiation of Mammalian Myotubes Induced by msx1
Odelberg, S. J., Kollhoff, A., & Keating, M. T. (2000) · Cell · doi:10.1016/s0092-8674(00)00212-9 · Cited by 446 · cited 1×
“Indeed, Msx2deficient mice exhibit a generalized skeletal osteoblast deficiency and a low turnover osteoporosis syndrome [52].”
BackgroundHMG-CoA Reductase Inhibitors and the Risk of Fractures
Meier, C. R. (2000) · JAMA · doi:10.1001/jama.283.24.3205 · Cited by 445
Banerjee, C., McCabe, L. R., Choi, J.-Y., Hiebert, S. W., Stein, J. L., Stein, G. S., & Lian, J. B. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970701)66:1<1::aid-jcb1>3.0.co;2-v · Cited by 438 · cited 1×
“Runx2 also forms a complex with Tcf/ Lef, comprising an important regulator of bone formation [50].”
BackgroundAortic calcification and the risk of osteoporosis and fractures.
Schulz, E., Arfai, K., Liu, X., Sayre, J., & Gilsanz, V. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030964 · Cited by 429 · cited 1×
“Regarding aortic calcification (a surrogate marker of the atherosclerotic burden), some studies reported an inverse relationship with BMD [12, 13].”
Non-trauma mortality in elderly women with low bone mineral density
Browner, W. S., Seeley, D. G., Cummings, S. R., & Vogt, T. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90489-c · Cited by 410 · cited 1×
“36), adjusted for age and duration of follow-up [9].”
Determinants of bone density in normal women: risk factors for future osteoporosis?
Stevenson, J. C., Lees, B., Devenport, M., Cust, M. P., & Ganger, K. F. (1989) · BMJ · doi:10.1136/bmj.298.6678.924 · Cited by 406 · cited 2×
“Apart from the fact that both diseases share common risk factors, such as hypertension [27], DM [28], smoking [29], alcohol abuse [30] and low level of physical activity [30], they have common pathogenetic pathways (Table 2).”
BackgroundThe association between low bone mass at the menopause and cardiovascular mortality
von der Recke, P., Hansen, M. A., & Hassager, C. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00028-5 · Cited by 402 · cited 2×
“It has been reported [7] that low bone mineral content in postmenopausal women was associated with increased mortality in later life, especially from cardiovascular disease (CVD) (about twofold increased risk of dying from CVD).”
Collin-Osdoby, P., Rothe, L., Anderson, F., Nelson, M., Maloney, W., & Osdoby, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010153200 · Cited by 398 · cited 1×
“OPG is also produced by cells of the cardiovascular system, including coronary artery smooth muscle cells and endothelial cells [40].”
Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
Lawson, J. A., FitzGerald, G. A., & Rokach, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24441 · Cited by 381 · cited 1×
“The two most extensively studied members of this family are 8isoprostaglandin F2a (isoPGF2a) and 8-isoprostaglandin E2a (isoPGE2a) [70].”
BackgroundHigh blood pressure and bone-mineral loss in elderly white women: a prospective study
Cappuccio, F. P., Meilahn, E., Zmuda, J. M., & Cauley, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01437-3 · Cited by 369
Isoprenoids as mediators of the biological effects of statins
Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352 · cited 1×
“Apart from reducing cholesterol biosynthesis, the inhibition of mevalonate also leads to a reduction in the synthesis of important intermediates, such as the isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate [93].”
BackgroundMerke, J., Milde, P., Lewicka, S., Hügel, U., Klaus, G., Mangelsdorf, D. J., Haussler, M. R., Rauterberg, E. W., & Ritz, E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114097 · Cited by 341 · cited 1×
“Vitamin D receptors (VDR) are present in endothelial [78] and smooth muscle cells [79] of the arterial wall.”
BackgroundCheng, S.-L., Shao, J.-S., Charlton-Kachigian, N., Loewy, A. P., & Towler, D. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306972200 · Cited by 334 · cited 1×
“It was also shown that Msx2 can act independently of Runx2, by Wnt/LRP5 signalling pathway [53].”
Manolagas, S. C., & Almeida, M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0259 · Cited by 330 · cited 1×
“Furthermore, emerging data suggest an antagonism of Wnt signalling by oxidative stress with increasing age, which may be a common molecular mechanism contributing to the development not only of osteoporosis, but also several pathologies such as atherosclerosis, insulin resistance and hyperlipidemia [ 48 ].”
Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease
Schoppet, M., Sattler, A. M., Schaefer, J. R., Herzum, M., Maisch, B., & Hofbauer, L. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020775 · Cited by 324 · cited 1×
“Increased OPG levels may therefore represent an insufficient compensatory mechanism to prevent further vascular damage [43].”
BackgroundBlood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304 · cited 1×
“Homocysteine is a possible risk factor for atherosclerosis [62].”
BackgroundRegulation of Bone Mass in Mice by the Lipoxygenase Gene Alox15
Klein, R. F., Allard, J., Avnur, Z., Nikolcheva, T., Rotstein, D., Carlos, A. S., Shea, M., Waters, R. V., Belknap, J. K., Peltz, G., et al. (2004) · Science · doi:10.1126/science.1090985 · Cited by 296 · cited 2×
“Moreover, the enzyme 12/15 lipoxygenase (12/15LO), which is responsible for the oxidative modification of LDL [67], plays a functional role in the modulation of oxidative stress and is active in bone and arterial wall [68].”
Angiotensin II accelerates osteoporosis by activating osteoclasts
Shimizu, H., Nakagami, H., Osako, M. K., Hanayama, R., Kunugiza, Y., Kizawa, T., Tomita, T., Yoshikawa, H., Ogihara, T., & Morishita, R. (2008) · The FASEB Journal · doi:10.1096/fj.07-098954 · Cited by 294 · cited 1×
“Furthermore, the use of an angiotensin II type 1 receptor blockade (olmesartan) appeared to attenuate this process [113].”
BackgroundOsteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal Women
Barengolts, E. I., Berman, M., Kukreja, S. C., Kouznetsova, T., Lin, C., & Chomka, E. V. (1998) · Calcified Tissue International · doi:10.1007/s002239900419 · Cited by 270 · cited 2×
“Barengolts [16] Coronary calcification 1998 45”
Rate of Bone Loss Is Associated with Mortality in Older Women: A Prospective Study
Kado, D. M., Browner, W. S., Blackwell, T., Gore, R., & Cummings, S. R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1974 · Cited by 259 · cited 2×
“A prospective study in women over 65 years old [8], reported that the same decrease in bone mineral density (BMD) of the femoral neck was followed by a 1.”
Parhami, F., Jackson, S. M., Tintut, Y., Le, V., Balucan, J. P., Territo, M., & Demer, L. L. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2067 · Cited by 259 · cited 1×
“It promotes bone loss by directing progenitor marrow stromal cells to undergo adipogenic instead of osteogenic differentiation, as indicated by a reduced expression of bone alkaline phosphatase (b-ALP) and osteocalcin, two markers of bone formation [65].”
BackgroundVascular calcification and osteoporosis—from clinical observation towards molecular understanding
Hofbauer, L. C., Brueck, C. C., Shanahan, C. M., Schoppet, M., & Dobnig, H. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0282-z · Cited by 248 · cited 3×
“Integrins comprise essential receptors for osteoclast migration to resorption sites [31].”
BackgroundInfluentialKhosla, S., Atkinson, E. J., Melton, L. J., & Riggs, B. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3946 · Cited by 247 · cited 1×
“A decrease in estrogen levels is associated with an increase in serum parathyroid hormone (PTH) [ 58 ].”
Vitamin K1 Supplementation Retards Bone Loss in Postmenopausal Women Between 50 and 60 Years of Age
Braam, L. A. J. L. M., Knapen, M. H. J., Geusens, P., Brouns, F., Hamuly�k, K., Gerichhausen, M. J. W., & Vermeer, C. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2084-4 · Cited by 239 · cited 1×
“As a result, reduced availability of vitamin K leads to functionally defective GLa proteins, with low affinity for the hydroxyapatite bone matrix and therefore low BMD [85].”
BackgroundKoh, J.-M., Khang, Y.-H., Jung, C.-H., Bae, S., Kim, D. J., Chung, Y.-E., & Kim, G. S. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1840-5 · Cited by 235 · cited 1×
“As far as CRP is concerned, the association between serum high sensitivity CRP (hs-CRP) levels and BMD in pre-and postmenopausal women was stronger in subjects with lower BMD, after adjustment for age, body mass index (BMI) and menopausal status, combined with higher serum total ALP activity (all, P for trend 75 ].”
BackgroundInteraction of calcium nutrition and physical activity on bone mass in young women
Kanders, B., Dempster, D. W., & Lindsay, R. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030204 · Cited by 227 · cited 1×
“Apart from the fact that both diseases share common risk factors, such as hypertension [27], DM [28], smoking [29], alcohol abuse [30] and low level of physical activity [30], they have common pathogenetic pathways (Table 2).”
BackgroundReid, I. R., Hague, W., Emberson, J., Baker, J., Tonkin, A., Hunt, D., MacMahon, S., & Sharpe, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04042-3 · Cited by 217 · cited 1×
“However, non-confirmatory data have arisen from a large randomized case-controlled trial, evaluating the effect of pravastatin use on the fracture rate, although this study involved a non osteoporotic population [100].”
Barrett-Connor, E., Mueller, J. E., von Mühlen, D. G., Laughlin, G. A., Schneider, D. L., & Sartoris, D. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6327 · Cited by 216 · cited 1×
“They are also expressed in osteoblasts as well as in chondrocytes in men, whose BMD is positively correlated with estrogen concentrations [ 57 ].”
Togari, A. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10121 · Cited by 213 · cited 1×
“The β-adrenergic stimulation of bone resorption might be mediated by directly activated osteoclasts [ 108 ].”
Osteoporosis and calcification of the aorta
Frye, M. A., Melton, L. J., Bryant, S. C., Fitzpatrick, L. A., Wahner, H. W., Schwartz, R. S., & Riggs, B. L. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90925-4 · Cited by 207 · cited 1×
“Some, but not all, studies reported a relationship dependent on age [1–6].”
Bauer, D. C., Mundy, G. R., Jamal, S. A., Black, D. M., Cauley, J. A., Ensrud, K. E., van der Klift, M., & Pols, H. A. P. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.2.146 · Cited by 206 · cited 1×
“Each study found a strong trend towards fewer hip fractures among women who reported the use of statins, even after adjusting for a number of other factors [99].”
Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta
Schmid, K., McSharry, W. O., Pameijer, C. H., & Binette, J. P. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90005-2 · Cited by 189 · cited 1×
“In particular, hydroxyapatite, the basic component of the mineral phase of bone, is also present in calcium deposits in atherosclerotic lesions [32].”
Stefenelli, T., Mayr, H., Bergler-Klein, J., Globits, S., Woloszczuk, W., & Niederle, B. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90260-v · Cited by 187 · cited 1×
“Increased PTH secretion results in accelerated bone loss and soft tissue calcium deposition, including vascular and myocardial calcification [59].”
BackgroundEffects of statins on bone mineral density: A meta-analysis of clinical studies
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2007) · Bone · doi:10.1016/j.bone.2007.02.019 · Cited by 185 · cited 2×
“The discrepancies observed between all these studies might be attributed to several reasons, including low and variable uptake of statins into bones, low systemic bioavailability (important hepatic first-pass effect), different sensitivities of osteoblasts and osteoclasts to statins, variable risk of osteoporosis betw…”
Increased plasma homocysteine after menopause
Hak, A. E., Polderman, K. H., Westendorp, I. C. D., Jakobs, C., Hofman, A., Witteman, J. C. M., & Stehouwer, C. D. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00321-4 · Cited by 185 · cited 1×
“Furthermore, estrogens may be inversely related to serum levels of homocysteine [ 60 ] and lipids, especially oxidized low density lipoprotein (LDL) [61].”
BackgroundReid, I. R., Ames, R. W., Orr-Walker, B. J., Clearwater, J. M., Horne, A. M., Evans, M. C., Murray, M. A. F., McNeil, A. R., & Gamble, G. D. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00510-6 · Cited by 181 · cited 1×
“Some studies demonstrated an effect of thiazide diuretics in preventing osteoporosis, perhaps by reducing the urinary calcium excretion [110, 111].”
Bone Changes and Carotid Atherosclerosis in Postmenopausal Women
Uyama, O., Yoshimoto, Y., Yamamoto, Y., & Kawai, A. (1997) · Stroke · doi:10.1161/01.str.28.9.1730 · Cited by 177 · cited 3×
“Previous studies have shown an association between osteoporosis and cardiovascular mortality [7–11], aortic and coronary calcification [12–16], carotid atherosclerosis [17–19], peripheral arterial disease [20] and stroke [21, 22] in both sexes, especially in women.”
BackgroundResultEffects of Atorvastatin on Vitamin D Levels in Patients With Acute Ischemic Heart Disease
Pérez-Castrillón, J. L., Vega, G., Abad, L., Sanz, A., Chaves, J., Hernandez, G., & Dueñas, A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.036 · Cited by 172 · cited 1×
“In a prospective study, simvastatin therapy was associated with an increase in serum osteocalcin concentration [96], while another study demonstrated an increase in the levels of vitamin D after administration of atorvastatin [97].”
BackgroundBone Mineral Density Is a Predictor of Survival
Johansson, C., Black, D., Johnell, O., Odén, A., & Mellström, D. (1998) · Calcified Tissue International · doi:10.1007/s002239900513 · Cited by 164 · cited 2×
“Johansson [26] Survival 1998 1924 198 Osteoporos Int (2009) 20:197–207”
Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women
MOOREN, M. J. V. D., WOUTERS, M. G. A. J., BLOM, H. J., SCHELLEKENS, L. A., ESKES, T. K. A. B., & ROLLAND, R. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01069.x · Cited by 163 · cited 1×
“9% decrease in plasma homocysteine levels in postmenopausal women continuously treated with micronised 17β-estradiol combined with cyclic dydrogesterone compared with baseline pre-hormone replacement levels [64].”
Schouten, F., Hirvonen, A., Maas, L. M., de Mol, B. A. J. M., Kleinjans, J. C. S., Bell, D. A., & Durrer, J. D. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1409 · Cited by 163 · cited 7×
“On the other hand, the frequency of BsmI B allele has been reported to be higher in patients with angiographically documented CAD [82] and DM [83], although one study found no relation at all [84].”
InfluentialThe Association of Bone Mineral Density with Vitamin D Receptor Gene Polymorphisms
Gong, G., Stern, H. S., Cheng, S.-C., Fong, N., Mordeson, J., Deng, H.-W., & Recker, R. R. (1999) · Osteoporosis International · doi:10.1007/s001980050116 · Cited by 161 · cited 1×
“In particular, the BSmI polymorphism has been associated with slowed calcium absorption and lower BMD [81].”
Determinants of the rate of bone loss in normal postmenopausal women
Reid, I. R. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.950 · Cited by 156
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
Hamerman, D. (2005) · QJM · doi:10.1093/qjmed/hci077 · Cited by 156 · cited 10×
“Pravastatin seems to be ineffective at increasing BMP-2 as it binds less strongly to plasma proteins than do other statins, such as lovastatin, simvastatin or fluvastatin [101].”
InfluentialBonnet, N., Gadois, C., McCloskey, E. V., Lemineur, G., Lespessailles, É., Courteix, D., & Benhamou, C. L. (2007) · Bone · doi:10.1016/j.bone.2007.01.006 · Cited by 155 · cited 1×
“Beta-blockers appear to induce bone formation and/or inhibit bone resorption in animals as well as reduce the risk of fracture in humans [106].”
BackgroundLynn, H., Kwok, T. C. Y., Wong, S. Y. S., Woo, J., & Leung, P. (2005) · Bone · doi:10.1016/j.bone.2005.09.011 · Cited by 154 · cited 1×
“Some studies associated their administration with an increase in hip and spine BMD [114] and others showed that ACE inhibition has no effect on the skeleton [115].”
BackgroundCardiovascular diseases and future risk of hip fracture in women
Sennerby, U., Farahmand, B. Y., Ahlbom, A., Ljunghall, S., & Michaëlsson, K. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0386-0 · Cited by 153 · cited 6×
“It has been reported [7] that low bone mineral content in postmenopausal women was associated with increased mortality in later life, especially from cardiovascular disease (CVD) (about twofold increased risk of dying from CVD).”
InfluentialVascular calcification and osteoporosis: inflammatory responses to oxidized lipids
Demer, L. L. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.4.737 · Cited by 151 · cited 1×
“The accumulation of oxidized lipids in tissue mimics chronic infection and thereby stimulates an immune response that promotes the hardening of soft tissue (to wall off infectious agents) and the softening of hard tissue (to dissolve a substrate for growth of infectious agents) [66].”
BackgroundDemonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cellsIn vitro
Merke, J., Hofmann, W. J., Goldschmidt, D., & Ritz, E. (1987) · Calcified Tissue International · doi:10.1007/bf02555253 · Cited by 151 · cited 1×
“Vitamin D receptors (VDR) are present in endothelial [78] and smooth muscle cells [79] of the arterial wall.”
Jørgensen, L., Engstad, T. A., & Jacobsen, B. K. (2001) · Stroke · doi:10.1161/01.str.32.1.47 · Cited by 150
TCF: transcriptional activator or repressor?
Bienz, M. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80013-6 · Cited by 149 · cited 1×
“This complex initiates an intracellular cascade of events leading to the stabilization of β-catenin and its subsequent translocation into the nucleus, where associated with the transcription factors Tcf/Lef, it triggers gene expression involving bone development [46].”
BackgroundMiyao, M., Morita, H., Hosoi, T., Kurihara, H., Inoue, S., Hoshino, S., Shiraki, M., Yazaki, Y., & Ouchi, Y. (2000) · Calcified Tissue International · doi:10.1007/s002230010038 · Cited by 145 · cited 1×
“There is also evidence that postmenopausal women with heterozygous mutation in MTHFR and therefore hyperhomocysteinemia demonstrate a decrease in BMD [63].”
BackgroundSinnott, B. P., Syed, I., Sevrukov, A., & Barengolts, E. I. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0244-z · Cited by 144 · cited 1×
“Some, but not all, studies reported a relationship dependent on age [1–6].”
BackgroundBone Mineral Density and Aortic Calcification: The Study of Osteoporotic Fractures
Vogt, M. T., Valentin, R. S., Forrest, K. Y. Z., Nevitt, M. C., & Cauley, J. A. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb04498.x · Cited by 141 · cited 1×
“Some, but not all, studies reported a relationship dependent on age [1–6].”
Tintut, Y., Parhami, F., Tsingotjidou, A., Tetradis, S., Territo, M., & Demer, L. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111551200 · Cited by 141 · cited 2×
“This was evidenced using tartrate-resistant acid phosphatase (TRAP) activity, a marker of bone resorption, which was increased after treatment of marrow-derived preosteoclasts with isoPGE2a [71].”
BackgroundMethodJie, K. G., Bots, M. L., Vermeer, C., Witteman, J. C. M., & Grobbee, D. E. (1996) · Calcified Tissue International · doi:10.1007/s002239900139 · Cited by 140 · cited 1×
“atherosclerotic calcification [87], providing evidence for its role in vascular mineralization.”
BackgroundBone Mineral Density and the Risk of Peripheral Arterial Disease: The Rotterdam Study
van der Klift, M., Pols, H. A. P., Hak, A. E., Witteman, J. C. M., Albert Hofman, D., & Laet, C. E. D. H. D. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-2076-9 · Cited by 136 · cited 2×
“[20] Peripheral artery disease 2002 5268”
Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities
Kühn, H., Belkner, J., Suzuki, H., & Yamamoto, S. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39770-4 · Cited by 132
Ortlepp, J. R., Lauscher, J. C., Hoffmann, R., Hanrath, P., & Joost, H. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00585.x · Cited by 131 · cited 1×
“On the other hand, the frequency of BsmI B allele has been reported to be higher in patients with angiographically documented CAD [82] and DM [83], although one study found no relation at all [84].”
Estrogens, bone loss and preservation
Christiansen, C., & Lindsay, R. (1990) · Osteoporosis International · doi:10.1007/bf01880410 · Cited by 126 · cited 1×
“It is well documented that women after the menopause demonstrate an accelerated bone loss, suggesting that estrogen deficiency plays a pivotal role in this process [54].”
Inflammatory markers and the risk of coronary heart disease in men and women
Pai, J. K., Pischon, T., & Ma, J. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.067 · Cited by 120
Low Bone Mineral Density Is Related to Echogenic Carotid Artery Plaques: A Population-based Study
Jörgensen, L. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh252 · Cited by 119 · cited 1×
“Two large epidemiological studies in older men have shown that low BMD is associated with increased severity of calcified carotid plaques [24] and CVD [25].”
Farhat, G. N., Strotmeyer, E. S., Newman, A. B., Sutton-Tyrrell, K., Bauer, D. C., Harris, T. B., Johnson, K., Taaffe, D. R., & Cauley, J. A. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0052-0 · Cited by 106 · cited 6×
“It has been reported [7] that low bone mineral content in postmenopausal women was associated with increased mortality in later life, especially from cardiovascular disease (CVD) (about twofold increased risk of dying from CVD).”
InfluentialSimvastatin Increases Serum Osteocalcin Concentration in Patients Treated for Hypercholesterolaemia
Chan, M. H. M., Mak, T. W.-L., Chiu, R. W. K., Chow, C., Chan, I. H.-S., & Lam, C. W.-K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.8001 · Cited by 91
Koshiyama, H., Nakamura, Y., Tanaka, S., & Minamikawa, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6748 · Cited by 90 · cited 1×
“Furthermore, etidronate, a biphosphonate, was suggested to have an inhibitory effect on atherosclerosis in patients with low bone mass [105].”
Role of innervation in the control of bone remodeling.
Chenu, C. (2004) · PubMed · Cited by 87
Bisphosphonates and atherosclerosis
Ylitalo, R. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00121-5 · Cited by 87
Osteoporosis of Lumbar Vertebrae and Calcification of Abdominal Aorta in Women Living in Durban
Dent, C. E., Engelbrecht, H. E., & Godfrey, R. C. (1968) · BMJ · doi:10.1136/bmj.4.5623.76 · Cited by 85 · cited 1×
“Some, but not all, studies reported a relationship dependent on age [1–6].”
Association between Systemic Calcified Atherosclerosis and Bone Density
Hyder, J. A., Allison, M., Criqui, M. H., & Wright, C. M. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9004-6 · Cited by 85 · cited 1×
“The prevalence of arterial calcium in the aorta (but not in carotid and coronary arteries, after adjustment for common risk factors) was also greater in both sexes with lower BMD in another study [14].”
Regulation of In Vitro Vascular Calcification by BMP4, VEGF and Wnt3a
Mikhaylova, L. M., Malmquist, J., & Nurminskaya, M. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9073-6 · Cited by 79 · cited 1×
“Wnt ligands have also been implicated in the regulation of the pathologic calcification in the vasculature, as well as the osteoblastic transdifferentiation of vascular smooth cells in vitro, although the exact mechanisms explaining this process have not been elucidated [47].”
BackgroundPEREZCASTRILLON, J. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00845-8 · Cited by 77 · cited 1×
“In particular, subjects presenting with the II+ID polymorphism exhibit a poor response to antihypertensive drug treatment with respect to bone mass, whereas those with the DD polymorphism seem to respond better [116].”
Shaffer, J. R., Kammerer, C. M., Rainwater, D. L., O’Leary, D. H., Bruder, J., Bauer, R. L., & Mitchell, B. D. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9079-0 · Cited by 76 · cited 1×
“In particular, they observed a negative association between IMT and BMD in both Mexican American men and women over 60 years of age [19].”
Hughes, A., Rogers, M. J., Idris, A. I., & Crockett, J. C. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9078-1 · Cited by 71 · cited 1×
“Prenylated signalling proteins are essential for osteoclast function, consistent with some observations that statins inhibit osteoclast activity in vitro [95].”
Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Paraskevas, K., Tzovaras, A., Briana, D., & Mikhailidis, D. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782794194 · Cited by 70 · cited 1×
“Statins appear to also exert beneficial effects on bone metabolism [91, 92].”
Self-citationMeisinger, C., Heier, M., Lang, O., & Döring, A. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0354-8 · Cited by 69 · cited 1×
“A large prospective population-based study associated the use of β-blockers with a reduced risk of fractures in middle-aged and older subjects from the general population [109].”
BackgroundPleiotropic effects of statins and related pharmacological experimental approaches
Alegret, M., & Silvestre, J. S. (2006) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2006.28.9.1003573 · Cited by 63 · cited 1×
“, Ras, Rho and Rac) that modulate a variety of cellular processes including cellular signalling, differentiation and proliferation [94].”
Ortlepp, J. R., Korff, A. V., Hanrath, P., Zerres, K., & Hoffmann, R. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01124.x · Cited by 59 · cited 1×
“On the other hand, the frequency of BsmI B allele has been reported to be higher in patients with angiographically documented CAD [82] and DM [83], although one study found no relation at all [84].”
BackgroundKim, B., Yu, Y. M., Kim, E. N., Chung, Y., Koh, J., & Kim, G. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02853.x · Cited by 57 · cited 1×
“Similar results were obtained from another study which showed that the increase in the levels of hs-CRP in pre-and post-menopausal women was followed by an increase in serum NTX, a marker of bone resorption, as mentioned above [76].”
Selby, P. L. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01021.x · Cited by 54 · cited 1×
“Apart from the fact that both diseases share common risk factors, such as hypertension [27], DM [28], smoking [29], alcohol abuse [30] and low level of physical activity [30], they have common pathogenetic pathways (Table 2).”
Tekin, G., Kekilli, E., Yağmur, J., Uçkan, A., Yağmur, C., Aksoy, Y., Turhan, H., & Yetkın, E. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.09.002 · Cited by 45 · cited 1×
“Von der Recke et al. [ 6 ] Cardiovascular mortality 1999 1063 Kado et al. [7] Cardiovascular mortality 2000 6046 Browner et al. [8] Cardiovascular mortality 1991 9704 Marcovitz et al. [9] Coronary artery disease 2005 209 Sennerby et al. [11] Cardiovascular disease 2007 4497 Kiel et al. [12] Aortic calcification 2001 5…”
BackgroundStimpel, M., Ma, Y., Yamamoto, N., & Chen, Y. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512010-00065 · Cited by 39 · cited 1×
“Some studies associated their administration with an increase in hip and spine BMD [114] and others showed that ACE inhibition has no effect on the skeleton [115].”
Jørgensen, L., Joakimsen, O., Mathiesen, E. B., Ahmed, L. A., Berntsen, G., Fønnebø, V. M., Joakimsen, R. M., Njølstad, I., Schirmer, H., & Jacobsen, B. K. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0071-x · Cited by 35 · cited 2×
“The prevalence of carotid echogenic plaques was significantly related to low BMD and the age-adjusted RR of fracture was higher among women with echogenic plaques than among those without: 1.7 (95% CI 1.0–2.7) [ 18 ].”
InfluentialIncreased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women
Mangiafico, R. A., Alagona, C., Pennisi, P. A., Parisi, N., Mangiafico, M., Purrello, F., & Fiore, C. E. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0438-5 · Cited by 33 · cited 2×
“Except for arterial calcium, the stiffness of the aorta, assessed by means of augmentation index and central aortic systolic and pulse pressures, was greater in osteoporotic postmenopausal women than control subjects [15].”
Athyros, V. G., Kakafika, A. I., Papageorgiou, A. A., Τζιόμαλος, Κ., Skaperdas, A., Pagourelias, E. D., Pyrpasopoulou, A., Karagiannis, A. I., Mikhailidis, D. P., & The GREACE Study Collaborative Group (2007) · Lipids · doi:10.1007/s11745-007-3103-z · Cited by 26
Self-citationCardiovascular diseases and future risk of hip fracture in women. Osteoporos Int
Sennerby, U., Farahmand, B. Y., Ahlbom, A., et al. (2007) · Cited by 23
Mangiafico, R. A., Malaponte, G., Pennisi, P., Volti, G. L., Trovato, G. M., Mangiafico, M., Bevelacqua, Y., Mazza, F., & Fiore, C. E. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01784.x · Cited by 21 · cited 1×
“Another study evaluating the role of isoPGF2a, showed increased levels in hypercholesterolaemic subjects, combined with lower bone mass and higher levels of b-ALP and osteocalcin than in normocholesterolaemic ones [72].”
Background
Cited by
Vitamin D in human reproduction: a narrative review: Vitamin D and reproduction
Anagnostis, P., Karras, S., & Goulis, D. G. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12031 · Cited by 174
Self-citationIncreased presence of capillaries next to remodeling sites in adult human cancellous bone
Kristensen, H. B., Andersen, T. L., Marcussen, N., Rolighed, L., & Delaisse, J.-M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1760 · Cited by 97
“It also provides a histological basis for emerging data, supporting the association between atherosclerosis and osteoporosis.((13,50)) Furthermore, this physical proximity fits the findings that oxygen pressure is critical for bone formation((27)) and that paracrine factors are the mediators of the interactions occurr…”
BackgroundLi, J., Zhang, Y., Zeng, X., Cheng, Y., Tang, L., Hong, D., & Yang, X. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108862 · Cited by 23
Metadata
- Authors
- Anagnostis, P., Karagiannis, A., Kakafika, A. I., Tziomalos, K., Athyros, V. G., & Mikhailidis, D. P.
- Venue
- Osteoporosis International
- Published
- 2008-05-29
- Volume
- 20
- Issue
- 2
- Pages
- 197-207
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2099897021
- Cited by
- 171
- References
- 109
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.